Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
25
SGRY Quote, Financials, Valuation and Earnings
Last price:
$17.39
Seasonality move
:
26.39%
Day range:
$16.80 - $17.44
52-week range:
$14.94 - $26.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.66x
P/B ratio:
1.27x
Volume:
1.4M
Avg. volume:
2.1M
1-year change:
-25.91%
Market cap:
$2.2B
Revenue:
$3.1B
EPS (TTM):
-$1.36
Analysts' Opinion
-
Consensus RatingSurgery Partners, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $25.73, Surgery Partners, Inc. has an estimated upside of 50.98% from its current price of $17.04.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $17.04.
Fair Value
-
According to the consensus of 11 analysts, Surgery Partners, Inc. has 50.98% upside to fair value with a price target of $25.73 per share.
SGRY vs. S&P 500
-
Over the past 5 trading days, Surgery Partners, Inc. has overperformed the S&P 500 by 0.88% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Surgery Partners, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Surgery Partners, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter Surgery Partners, Inc. reported revenues of $821.5M.
Earnings Growth
-
Surgery Partners, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Surgery Partners, Inc. reported earnings per share of -$0.18.
Enterprise value:
7.7B
EV / Invested capital:
1.04x
Price / LTM sales:
0.66x
EV / EBIT:
15.21x
EV / Revenue:
2.34x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
39.65x
Price / Operating cash flow:
11.13x
Enterprise value / EBITDA:
11.73x
Gross Profit (TTM):
$636.4M
Return On Assets:
0.3%
Net Income Margin (TTM):
0.71%
Return On Equity:
0.65%
Return On Invested Capital:
0.32%
Operating Margin:
16.24%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $2.7B | $3B | $3.3B | $770.4M | $821.5M | |
| Gross Profit | $521.6M | $555.8M | $636.4M | $127.3M | $155.8M | |
| Operating Income | $392.9M | $432.2M | $505.9M | $98.1M | $133.4M | |
| EBITDA | $535.4M | $582M | $655.9M | $148.3M | $172.9M | |
| Diluted EPS | -$0.32 | -$0.48 | -$1.36 | -$0.25 | -$0.18 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $841.7M | $738.3M | $876.2M | $1B | $1.1B | |
| Total Assets | $5.6B | $6.5B | $6.8B | $7.5B | $7.9B | |
| Current Liabilities | $540.5M | $624.3M | $501.4M | $575.2M | $586M | |
| Total Liabilities | $3.8B | $4.1B | $3.5B | $4B | $4.4B | |
| Total Equity | $1.9B | $2.4B | $3.3B | $3.5B | $3.6B | |
| Total Debt | $3.2B | $3.5B | $2.9B | $3.5B | $3.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $238.4M | $251.3M | $282.3M | $65.2M | $83.6M | |
| Cash From Investing | -$239.7M | -$434.9M | -$232.2M | -$49.6M | -$46.2M | |
| Cash From Financing | $82.5M | $169.4M | -$68.5M | -$7.3M | -$84.1M | |
| Free Cash Flow | $146.7M | $163.4M | $194.1M | $45M | $63.8M | |
SGRY
Sector
Market Cap
$2.2B
$28.4M
Price % of 52-Week High
65.14%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-3.17%
-1.32%
1-Year Price Total Return
-25.91%
-22.19%
Beta (5-Year)
1.932
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$16.76
200-day SMA
Sell
Level
$21.91
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$16.93
Relative Strength Index (RSI14)
Sell
Level
45.90
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-16.6667
50-day SMA
Sell
Level
$19.61
MACD (12, 26)
Sell
Level
-0.91
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8905)
Sell
CA Score
(Annual)
Level (-1.172)
Buy
Beneish M-Score
(Annual)
Level (-2.634)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (5.0367)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.
Stock Forecast FAQ
In the current month, SGRY has received 8 Buy ratings 3 Hold ratings, and 0 Sell ratings. The SGRY average analyst price target in the past 3 months is $25.73.
-
Where Will Surgery Partners, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Surgery Partners, Inc. share price will rise to $25.73 per share over the next 12 months.
-
What Do Analysts Say About Surgery Partners, Inc.?
Analysts are divided on their view about Surgery Partners, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Surgery Partners, Inc. is a Sell and believe this share price will drop from its current level to $18.00.
-
What Is Surgery Partners, Inc.'s Price Target?
The price target for Surgery Partners, Inc. over the next 1-year time period is forecast to be $25.73 according to 11 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is SGRY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Surgery Partners, Inc. is a Buy. 8 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SGRY?
You can purchase shares of Surgery Partners, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Surgery Partners, Inc. shares.
-
What Is The Surgery Partners, Inc. Share Price Today?
Surgery Partners, Inc. was last trading at $17.39 per share. This represents the most recent stock quote for Surgery Partners, Inc.. Yesterday, Surgery Partners, Inc. closed at $17.04 per share.
-
How To Buy Surgery Partners, Inc. Stock Online?
In order to purchase Surgery Partners, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SGRY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SGRY
Sector
P/E ratio
--
23.66x
PEG ratio
-0.07x
-0.01x
P/B ratio
1.27x
1.84x
Price / LTM sales
0.66x
1.60x
Growth Metrics
SGRY
Sector
Revenue growth
6.63%
4.85%
Earnings growth
28.98%
11.15%
Revenue (5-year growth)
11.2%
6.45%
Earnings forecast
$0.16
-$0.20
Profitability
SGRY
Sector
Profitability FY 2024
$593M
$3.6M
Return on invested capital
0.32%
-30.98%
Return on assets
0.3%
-27.62%
Return on equity
0.65%
-36.69%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
2
Estimated Next Earnings Date
Feb
9
Balance Sheet
SGRY
Sector
Total cash
$203.4M
$27.2M
Short term investments
--
$25.7M
Total assets
$8B
$79.9M
Long term debt
$3.8B
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
